Vimarsana
Biggest News Aggregation in the World

Page 16 - Aadi Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aadi Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aadi Bioscience Today - Breaking & Trending Today

Aadi Bioscience Announces Multiple Presentations on nab-Sirolimus at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting - Vimarsana News

Aadi Bioscience Announces Multiple Presentations on nab-Sirolimus at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

/PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision...

Head-To-Head Contrast: Aadi Bioscience (NASDAQ:AADI) versus Arvinas (NASDAQ:ARVN) - Vimarsana News

Head-To-Head Contrast: Aadi Bioscience (NASDAQ:AADI) versus Arvinas (NASDAQ:ARVN)

Aadi Bioscience (NASDAQ:AADI – Get Rating) and Arvinas (NASDAQ:ARVN – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, dividends, profitability, risk, institutional ownership and earnings. Valuation & Earnings This table compares Aadi Bioscience and Arvinas’ […]

Editas Medicine Strengthens Board of Directors with Appointment of New Chair and New Director - Vimarsana News

Editas Medicine Strengthens Board of Directors with Appointment of New Chair and New Director

Emma Reeve to support Editas’ evolution in new role as Chair of the Board Elliott Levy, M.D., joins Board as an Independent Director CAMBRIDGE, Mass., April 13, 2023 -- Editas... | April 13, 2023

Aadi Bioscience : Corporate Presentation - Vimarsana News

Aadi Bioscience : Corporate Presentation

Corporate Presentation April 2023 Forward-Looking Statements ... | April 10, 2023

Aadi Bioscience, Inc. (NASDAQ:AADI) Chairman Sells $71,393.35 in Stock - Vimarsana News

Aadi Bioscience, Inc. (NASDAQ:AADI) Chairman Sells $71,393.35 in Stock

Aadi Bioscience, Inc. (NASDAQ:AADI – Get Rating) Chairman Neil Desai sold 9,583 shares of the business’s stock in a transaction that occurred on Monday, April 3rd. The stock was sold at an average price of $7.45, for a total value of $71,393.35. Following the completion of the transaction, the chairman now directly owns 1,905,960 shares […]

Source: wkrb13.com